ACTH Regulates Steroidogenic Gene Expression and Cortisol Biosynthesis in the Human Adrenal Cortex via Sphingolipid Metabolism
Tuba Ozbay , Alfred H. Merrill , Marion B. Sewer
Endocrine Research 30 ( 4) 787 -794
21
2004
Nordihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer.
Danica L. Rowe , Tuba Ozbay , Laura M. Bender , Rita Nahta
Molecular Cancer Therapeutics 7 ( 7) 1900 -1908
47
2008
A Novel Unidirectional Cross-Talk from the Insulin-Like Growth Factor-I Receptor to Leptin Receptor in Human Breast Cancer Cells
Tuba Ozbay , Rita Nahta
Molecular Cancer Research 6 ( 6) 1052 -1058
28
2008
Cyclic adenosine 5'-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1.
Tuba Ozbay , Anne Rowan , Adam Leon , Pritty Patel
Endocrinology 147 ( 3) 1427 -1437
57
2006
In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells.
Tuba Ozbay , Donald L. Durden , Tongrui Liu , Ruth M. O’Regan
Cancer Chemotherapy and Pharmacology 65 ( 4) 697 -706
36
2010
Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin
Danica L. Rowe , Tuba Ozbay , Ruth M. O'Regan , Rita Nahta
Breast Cancer: Basic and Clinical Research 3 ( 3) 61 -75
91
2009
Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines
Tuba Ozbay , Rita Nahta
Breast Cancer: Basic and Clinical Research 5 ( 5) 143 -154
38
2011
The Role of Sphingolipids in Cortisol Synthesis in the Adrenal Cortex
Tuba Selcuk Ozbay
Georgia Institute of Technology
2005
Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens
R. Nahta , S. Shabaya , T. Ozbay , D. Rowe
Current Pharmacogenomics and Personalized Medicine 7 ( 4) 263 -274
56
2009